Establishment Labs Holdings Inc (ESTA) Stock Analysis
Breakout setup
Healthcare · Medical Devices
Sell if holding. Engine safety override at $66.11: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: High short interest: 20%; Below-average business quality.
Establishment Labs is a global medical device company selling Motiva silicone gel breast implants (registered in 100+ countries) for augmentation and reconstruction, with U.S. commercial launch beginning October 2024. Revenue is primarily from Motiva Implants sales via exclusive... Read more
Sell if holding. Engine safety override at $66.11: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: High short interest: 20%; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 61, MACD bullish. Score 5.4/10, moderate confidence.
Passes 5/8 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.70, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSuppliersingle-source, third-party supplier for medical-grade long-term implantable silicone10-K Item 1A: 'We rely on a single-source, third-party supplier for medical-grade long-term implantable silicone, which is the primary raw material used in our Motiva Implants'
- HIGHProductMotiva Implants10-K Item 1A: 'our ability to achieve and maintain profitability depends on the commercial success of our Motiva Implants'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers·1 ceiling hit
Risk profile below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Unprofitable operations — net margin -24.2%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $66.11: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: High short interest: 20%; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 61, MACD bullish. Prior stop was $61.48. Score 5.4/10, moderate confidence.
Take-profit target: $76.56 (+15.8% upside). Prior stop was $61.48. Stop-loss: $61.48.
Concentration risk — Supplier: single-source, third-party supplier for medical-grade long-term implantable silicone; Concentration risk — Product: Motiva Implants; Quality below floor (3.6 < 4.0).
Establishment Labs Holdings Inc trades at a P/E of N/A (forward 308.3). TrendMatrix value score: 5.2/10. Verdict: Sell.
15 analysts cover ESTA with a consensus score of 4.2/5. Average price target: $88.
What does Establishment Labs Holdings Inc do?Establishment Labs is a global medical device company selling Motiva silicone gel breast implants (registered in 100+...
Establishment Labs is a global medical device company selling Motiva silicone gel breast implants (registered in 100+ countries) for augmentation and reconstruction, with U.S. commercial launch beginning October 2024. Revenue is primarily from Motiva Implants sales via exclusive distributors and direct sales force; net loss was $124.5M in 2025.